16.04.2026After 6 years of development, VitroFlow.Bio is ready for early customer access 🚀🧪 We built this platform because we kept…
23.03.2026The FDA recently released new draft guidance on the use of New Approach Methodologies (NAMs) in drug development, marking another…- 12.03.2026🔬 We were proud to be a sponsor of the 2nd Bonn Organoid Symposium 2026. On March 12, the Rheinische…
28.02.2026Great to be back at Session 3 of the Creative Destruction Lab (CDL) Health Stream in Heidelberg. 🚀 The session…
23.02.2026📢 We’re proud to see VitrofluidiX mentioned in Preqin First Close Weekly (January 23, 2026). In this edition, Preqin highlights…- 16.02.2026We’ve moved! 🚀📍VitrofluidiX has officially relocated to the RTZ Köln. Our new location provides a larger lab, an expanded workshop,…
- 09.02.2026Last week, our CEO Carlotta Altringer attended the DxPx Conference in Munich, one of the key events for innovation in…
31.01.2026We’re happy to share that deutsche-startups.de recently featured VitrofluidiX. In the interview, our co-founder David Günter reflects on how VitrofluidiX…- 23.01.20262025 was a year full of exciting developments, new learnings, and inspiring encounters with great people along the way.🔬 Product…
- 19.12.2025The UK government has published a new roadmap aimed at accelerating the transition away from animal testing by supporting alternative,…
